Corvus Pharmaceuticals
CRVS
CRVS
55 hedge funds and large institutions have $288M invested in Corvus Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 54 → 55 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
55
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$19.6M | |
| 2 | +$17.2M | |
| 3 | +$14.7M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$13.6M |
| 5 |
O
OrbiMed
New York
|
+$6.78M |
Top Sellers
| 1 | -$4.83M | |
| 2 | -$1.37M | |
| 3 | -$314K | |
| 4 |
SIM
Spark Investment Management
New York
|
-$203K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$186K |